Windlas Biotech Standalone June 2024 Net Sales at Rs 175.15 crore, up 20.97% Y-o-Y
August 17, 2024 / 10:35 IST
Reported Standalone quarterly numbers for Windlas Biotech are:Net Sales at Rs 175.15 crore in June 2024 up 20.97% from Rs. 144.79 crore in June 2023.
Quarterly Net Profit at Rs. 13.48 crore in June 2024 up 11.71% from Rs. 12.07 crore in June 2023.
EBITDA stands at Rs. 25.01 crore in June 2024 up 26.5% from Rs. 19.77 crore in June 2023.
Windlas Biotech EPS has increased to Rs. 6.47 in June 2024 from Rs. 5.79 in June 2023.
| Windlas Biotech shares closed at 832.50 on August 14, 2024 (NSE) and has given 63.62% returns over the last 6 months and 111.29% over the last 12 months. |
| Windlas Biotech | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 175.15 | 171.29 | 144.79 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 175.15 | 171.29 | 144.79 | | EXPENDITURE | | Consumption of Raw Materials | -2.26 | 106.61 | 89.27 | | Purchase of Traded Goods | 118.48 | -- | -- | | Increase/Decrease in Stocks | -6.82 | 0.55 | 2.24 | | Power & Fuel | -- | -- | -- | | Employees Cost | 27.85 | 22.85 | 20.56 | | Depreciation | 6.21 | 3.54 | 3.19 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 17.02 | 19.35 | 15.58 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 14.67 | 18.40 | 13.95 | | Other Income | 4.13 | 4.44 | 2.62 | | P/L Before Int., Excpt. Items & Tax | 18.80 | 22.84 | 16.58 | | Interest | 0.49 | 0.28 | 0.24 | | P/L Before Exceptional Items & Tax | 18.31 | 22.56 | 16.34 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 18.31 | 22.56 | 16.34 | | Tax | 4.83 | 5.61 | 4.28 | | P/L After Tax from Ordinary Activities | 13.48 | 16.95 | 12.07 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 13.48 | 16.95 | 12.07 | | Equity Share Capital | 10.45 | 10.40 | 10.40 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 6.47 | 8.15 | 5.79 | | Diluted EPS | 6.44 | 8.12 | 5.79 | | EPS After Extra Ordinary | | Basic EPS | 6.47 | 8.15 | 5.79 | | Diluted EPS | 6.44 | 8.12 | 5.79 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
